U.S. Food and Drug Administration | Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention @US_FDA | Uploaded 1 week ago | Updated 12 hours ago
Are you a health care professional and want to learn more about the current state of the opioid crisis and what we can do to prevent drug overdoses and reduce deaths? Clinicians hear directly from the FDA, SAMHSA, NIH and AHRQ about the latest in overdose prevention.
Presenters include:
• Hilary Marston, M.D., M.P.H., Chief Medical Officer, Office of the Commissioner, FDA
• Josh Rising, M.D., M.P.H., Senior Clinical Advisor, Office of the Commissioner, FDA
• Marta Sokolowska, Ph.D., Deputy Center Director for Substance Use and Behavioral Health, Center for Drug Evaluation and Research, FDA
• CAPT Christopher M. Jones, Pharm.D., Dr.P.H., M.P.H., Director, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration
• Wilson M. Compton, M.D., M.P.E., Deputy Director, National Institute on Drug Abuse, National Institutes of Health
• Laura L. Sessums, J.D., M.D., Chief Physician, Office of the Director, Agency for Healthcare Research and Quality